CN113336876A - Use of gamma, delta-unsaturated oxime ester compounds as photoinitiators - Google Patents

Use of gamma, delta-unsaturated oxime ester compounds as photoinitiators Download PDF

Info

Publication number
CN113336876A
CN113336876A CN202110659660.0A CN202110659660A CN113336876A CN 113336876 A CN113336876 A CN 113336876A CN 202110659660 A CN202110659660 A CN 202110659660A CN 113336876 A CN113336876 A CN 113336876A
Authority
CN
China
Prior art keywords
radical
alkyl
ring members
aryl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110659660.0A
Other languages
Chinese (zh)
Inventor
李治全
邹应全
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HUBEI GURUN TECHNOLOGY CO LTD
Original Assignee
HUBEI GURUN TECHNOLOGY CO LTD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUBEI GURUN TECHNOLOGY CO LTD filed Critical HUBEI GURUN TECHNOLOGY CO LTD
Priority to CN202110659660.0A priority Critical patent/CN113336876A/en
Publication of CN113336876A publication Critical patent/CN113336876A/en
Priority to PCT/CN2022/097591 priority patent/WO2022257957A1/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/46Polymerisation initiated by wave energy or particle radiation
    • C08F2/48Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/12Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reactions not involving the formation of oxyimino groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32Oximes
    • C07C251/62Oximes having oxygen atoms of oxyimino groups esterified
    • C07C251/64Oximes having oxygen atoms of oxyimino groups esterified by carboxylic acids
    • C07C251/66Oximes having oxygen atoms of oxyimino groups esterified by carboxylic acids with the esterifying carboxyl groups bound to hydrogen atoms, to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/86Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to the use of gamma, delta-unsaturated oxime ester compounds of formula (I) wherein the variables are as defined in the description, as photoinitiators. The invention also relates to a preparation method of the gamma, delta-unsaturated oxime ester compound. The gamma, delta-unsaturated compounds of the inventionAnd oxime ester compounds have excellent initiation efficiency as photoinitiators.

Description

Use of gamma, delta-unsaturated oxime ester compounds as photoinitiators
Technical Field
The invention relates to the field of photoinitiators, in particular to application of a gamma, delta-unsaturated oxime ester compound as a photoinitiator.
Background
The photocuring technology with the 5E characteristic (high efficiency, wide adaptability, economy, energy conservation and environmental protection) is widely applied to the traditional fields of coatings, adhesives, printing ink and the like and the high and new technologies of photoresist, 3D printing and the like. The photo-curing system mainly comprises oligomer, monomer, photoinitiator, auxiliary agent and the like, wherein the photoinitiator is a core component of the photo-curing system and has the function of generating active species (free radicals, cations and the like) after absorbing light energy and initiating the monomer and the oligomer in the system to carry out polymerization crosslinking, so that the activity of the photoinitiator has a decisive influence on the photo-curing rate and the curing degree.
Oxime ester photoinitiators are excellent high-sensitivity photoinitiators, which can generate active free radicals to initiate polymerization through irreversible decarboxylation after absorbing light energy, and currently, the most widely used commercial oxime ester photoinitiators are OXE-1 and OXE 2. It is to be noted that the photosensitivity of a photoinitiator is not only dependent on its absorption properties, but also its quantum yield of active radicals is an important determinant. The quantum yield of active free radicals of the oxime ester photoinitiator reported at present is lower than that of the traditional I-type UV photoinitiator, such as alpha-dialkoxy acetophenone, alpha-hydroxy alkyl benzophenone, alpha-amino alkyl benzophenone and the like. Therefore, how to break through the quantum yield limit of active free radicals of the oxime ester photoinitiator is the key for effectively improving the sensitivity of the photoinitiator.
Disclosure of Invention
In order to solve the problems, the invention provides the application of gamma, delta-unsaturated oxime ester serving as a photoinitiator. The oxime ester initiator of the present invention has excellent initiation efficiency when used as a photoinitiator due to its specific molecular structure.
Accordingly, it is an object of the present invention to provide a use of a γ, δ -unsaturated oxime ester compound as a photoinitiator, which has excellent initiation efficiency.
It is another object of the present invention to provide a process for preparing the gamma, delta-unsaturated oxime ester compounds of the present invention. The method is simple and easy to implement, mild in condition, easy to obtain raw materials and low in price.
The technical solution for achieving the above object of the present invention can be summarized as follows:
1. use of a gamma, delta-unsaturated oxime ester compound of formula (I) as a photoinitiator,
Figure BDA0003113238590000021
wherein R is1、R2、R3、R4And R5Independently of one another, hydrogen, halogen, nitro, cyano, amino, mono (C)1-C6Alkyl) amino, di (C)1-C6Alkyl) amino, C1-C20Alkoxy radical, C1-C20Alkyl radical, C1-C20Haloalkyl, C3-C10Cycloalkyl radical, C4-C20Cycloalkylalkyl radical, C4-C20Alkyl cycloalkyl radical, C3-C10Cycloalkoxy, C4-C20Cycloalkylalkoxy radical, C2-C20Alkenyl radical, C6-C18Aryl of (C)7-C20Aralkyl radical, C7-C20Alkylaryl and C6-C20An aryloxy group;
R6is represented by C1-C20Alkyl radical, C1-C20Haloalkyl, C3-C10Cycloalkyl radical, C4-C20Cycloalkylalkyl radical, C4-C20Alkyl cycloalkyl radical, C6-C20Aryl radical, C7-C20Aralkyl and C7-C20An alkylaryl group; and
ar represents an aryl group or a heteroaryl group.
2. The use according to item 1, wherein R1、R2、R3、R4And R5Independently of one another, hydrogen, halogen, nitro, cyano, amino, mono (C)1-C6Alkyl) amino, di (C)1-C6Alkyl) amino, C1-C12Alkoxy radical, C1-C12Alkyl radical, C1-C12Haloalkyl, C3-C8Cycloalkyl radical, C4-C12Cycloalkylalkyl radical, C4-C12Alkyl cycloalkyl radical, C3-C8Cycloalkoxy, C4-C12Cycloalkylalkoxy radical, C2-C6Alkenyl radical, C6-C10Aryl of (C)7-C12Aralkyl radical, C7-C12Alkylaryl and C6-C10An aryloxy group;
preferably, R is1、R2、R3、R4And R5Independently of one another, hydrogen, halogen, amino, mono (C)1-C4Alkyl) amino, di (C)1-C4Alkyl) amino, C1-C6Alkyl radical, C1-C6Haloalkyl, C3-C8Cycloalkyl radical, C4-C8Cycloalkylalkyl radical, C4-C8Alkyl cycloalkyl radical, C2-C6Alkenyl radical, C6-C10Aryl and C7-C12An alkylaryl group;
more preferably R1、R2、R3、R4And R5Independently of one another, hydrogen, halogen, amino, mono (C)1-C4Alkyl) amino, di (C)1-C4Alkyl) amino, C1-C6Haloalkyl and C1-C6An alkyl group.
3. The use according to item 1 or 2, wherein R6Is represented by C1-C12Alkyl radical, C1-C12Haloalkyl, C3-C8Cycloalkyl radical, C4-C12Cycloalkylalkyl radical, C4-C12Alkyl cycloalkyl radical, C6-C10Aryl radical, C7-C11Aralkyl and C7-C11An alkylaryl group;
preferably, R is6Is represented by C1-C6Alkyl radical, C1-C6Haloalkyl, C3-C6Cycloalkyl radical, C4-C8Cycloalkylalkyl radical, C4-C8Alkyl cycloalkyl radical, C6-C10Aryl radical, C7-C11Aralkyl and C7-C11An alkylaryl group;
more preferably, R6Is represented by C1-C6Alkyl radical, C1-C6Haloalkyl, C5-C6Cycloalkyl radicals, quilt C5-C6Cycloalkyl-substituted C1-C6Alkyl, phenyl or C substituted by phenyl1-C6An alkyl group;
most preferred is R6Is C1-C6An alkyl group.
4. Use according to any one of items 1 to 3, wherein Ar represents C6-C30Aryl or heteroaryl having 5 to 18 ring members, wherein said aryl or heteroaryl is unsubstituted or substituted with one or more groups independently selected from the group consisting of: hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-8 ring members, or amino;
preferably Ar represents C6-C20Aryl or heteroaryl having 5 to 18 ring members, wherein said aryl or heteroaryl is unsubstituted or substituted with one or more groups independently selected from the group consisting of: hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-8 ring members, or amino;
more preferably Ar represents C6-C14Aryl or heteroaryl having 5 to 14 ring members, wherein said aryl or heteroaryl is unsubstituted or substituted with one or more groups independently selected from the group consisting of: hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5 to 8 ring members or amino,
in particular Ar is a heteroaryl group having two or three fused rings and having 8 to 14, or 9 to 14 or 9 to 13 ring members, the heteroaryl group having 1 or 2N atoms as ring members, the heteroaryl group being unsubstituted or substituted by one or more groups independently selected from: hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-8 ring members, or amino.
5. Use according to any one of items 1 to 4, wherein the variables in the compound of formula (I) have the following definitions:
R1、R2、R3、R4and R5Independently of one another, hydrogen, halogen, amino, mono (C)1-C4Alkyl) amino, di (C)1-C4Alkyl) amino, C1-C6Alkyl radical, C1-C6Haloalkyl, C3-C8Cycloalkyl radical, C4-C8Cycloalkylalkyl radical, C4-C8Alkyl cycloalkyl radical, C2-C6Alkenyl radical, C6-C10Aryl and C7-C12An alkylaryl group;
R6is represented by C1-C6Alkyl radical, C1-C6Haloalkyl, C3-C6Cycloalkyl radical, C4-C8Cycloalkylalkyl radical, C4-C8Alkyl cycloalkyl radical, C6-C10Aryl radical, C7-C11Aralkyl and C7-C11An alkylaryl group; and
ar represents C6-C20Aryl or heteroaryl having 5 to 18 ring members, wherein said aryl or heteroaryl is unsubstituted or substituted with one or more groups independently selected from the group consisting of: hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-8 ring members, or amino.
6. Use according to any one of items 1 to 5, wherein the variables in the compound of formula (I) have the following definitions:
R1、R2、R3、R4and R5Independently of one another, hydrogen, halogen, amino, mono (C)1-C4Alkyl) amino, di (C)1-C4Alkyl) amino and C1-C6An alkyl group;
R6is represented by C1-C6Alkyl radical, C5-C6Cycloalkyl radicals, quilt C5-C6Cycloalkyl-substituted C1-C6Alkyl, phenyl or C substituted by phenyl1-C6An alkyl group; and
ar represents C6-C14Aryl radicals or radicalsHeteroaryl having 5 to 14 ring members, wherein said aryl or heteroaryl is unsubstituted or substituted with one or more groups independently selected from the group consisting of: hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-8 ring members, or amino.
7. Use according to any one of items 1 to 6, wherein the compound of formula (I) is selected from the following compounds:
Figure BDA0003113238590000051
8. use according to any one of items 1 to 7 for the irradiation of a photocuring system with a wavelength of 300-550nm, preferably 350-525nm, in particular for 3D printing.
9. A γ, δ -unsaturated oxime ester compound of formula (I):
Figure BDA0003113238590000052
wherein R is1、R2、R3、R4、R5And R6As defined in any of items 1 to 7, and
ar is a heteroaryl group having two or three fused rings and having 8-14, or 9-14 or 9-13 ring members, the heteroaryl group having 1 or 2N atoms as ring members, the heteroaryl group being unsubstituted or substituted with one or more groups independently selected from: hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl having 5-10 ring members of heteroaryl, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-8 ring members, or amino.
10. A compound according to item 9, which is
Figure BDA0003113238590000061
11. A process for the preparation of a compound of formula (I) as defined in any one of claims 1 to 10, which comprises reacting a compound of formula (E)
Figure BDA0003113238590000062
Wherein R is1、R2、R3、R4、R5And Ar is as defined in any one of items 1 to 10,
reacting with a compound of formula (F) to give a compound of formula (I)
Figure BDA0003113238590000063
Wherein X1Is halogen, hydroxy or-C (═ O) -R6And R6As defined in any one of items 1 to 10.
12. The process according to item 11, which comprises subjecting the compound of formula (C) to oximation reaction with hydroxylamine and/or hydroxylamine hydrochloride to obtain a compound of formula (E)
Figure BDA0003113238590000071
Wherein R is1、R2、R3、R4、R5And Ar is as defined in any one of items 1 to 10.
13. A method according to item 12, which comprises reacting a compound of formula (A)
Ar-H
(A)
Wherein Ar is as defined in any one of items 1 to 10,
with a compound of formula (B) to prepare a compound of formula (C)
Figure BDA0003113238590000072
Wherein R is1、R2、R3、R4、R5And Ar is as defined in any one of items 1 to 10, and X2Is halogen.
14. A photocurable composition comprising at least one γ, δ -unsaturated oxime ester compound of formula (I) according to any one of items 1 to 10.
15. A cured material obtainable from the photocurable composition of item 14.
Drawings
Fig. 1 shows uv-vis absorption spectra of compound 2 and compound 3 in examples of the present invention.
FIG. 2 is a graph of the real-time infrared conversion of monomers for an acrylate system comprising Compound 1 of example 1 of the present invention and a reference compound, respectively.
Fig. 3 is a digital photograph of a 3D print molded structure obtained using compound 3 of example 3 of the present invention as a photoinitiator.
FIG. 4 is a bar graph of monomer conversion in samples using compounds 1,2, or 3.
Detailed Description
In a first aspect the present invention provides the use of a gamma, delta-unsaturated oxime ester compound of formula (I):
Figure BDA0003113238590000081
wherein R is1、R2、R3、R4And R5Independent of each otherAnd represents hydrogen, halogen, nitro, cyano, amino, mono (C)1-C6Alkyl) amino, di (C)1-C6Alkyl) amino, C1-C20Alkoxy radical, C1-C20Alkyl radical, C1-C20Haloalkyl, C3-C10Cycloalkyl radical, C4-C20Cycloalkylalkyl radical, C4-C20Alkyl cycloalkyl radical, C3-C10Cycloalkoxy, C4-C20Cycloalkylalkoxy radical, C2-C20Alkenyl radical, C6-C18Aryl of (C)7-C20Aralkyl radical, C7-C20Alkylaryl and C6-C20An aryloxy group;
R6is represented by C1-C20Alkyl radical, C1-C20Haloalkyl, C3-C10Cycloalkyl radical, C4-C20Cycloalkylalkyl radical, C4-C20Alkyl cycloalkyl radical, C6-C20Aryl radical, C7-C20Aralkyl and C7-C20An alkylaryl group; and
ar represents an aryl group or a heteroaryl group.
In the present invention, the prefix "Cn-Cm"in each case denotes that the number of carbon atoms contained in the radical is n to m.
"halogen" refers to fluorine, chlorine, bromine and iodine. In the present invention, it is preferred that the halogen comprises F, Cl or a combination thereof.
The term "C" as used hereinn-CmAlkyl "means a saturated hydrocarbon radical having n to m, for example 1 to 20, preferably 1 to 12, more preferably 1 to 8, particularly preferably 1 to 6, particularly preferably 1 to 4, carbon atoms, which may be branched or unbranched. Examples include methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1-dimethylethyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2-dimethylpropyl, 1-ethylpropyl, hexyl, 1-dimethylpropyl, 1, 2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpropylCyclopentyl, 1-dimethylbutyl, 1, 2-dimethylbutyl, 1, 3-dimethylbutyl, 2, 2-dimethylbutyl, 2, 3-dimethylbutyl, 3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1, 2-trimethylpropyl, 1,2, 2-trimethylpropyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, heptyl, octyl, 2-ethylhexyl, nonyl, decyl, undecyl, dodecyl and isomers thereof. C1-C8The alkyl group may be methyl, ethyl, propyl, isopropyl, n-butyl, 2-butyl, t-butyl, pentyl, isopentyl, hexyl, heptyl, octyl, and isomers thereof. C1-C6The alkyl group may be methyl, ethyl, propyl, isopropyl, n-butyl, 2-butyl, t-butyl, pentyl, isopentyl, hexyl and isomers thereof. C1-C4The alkyl group may be methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1-dimethylethyl, and isomers thereof.
“C1-C20Haloalkyl "includes C1-C12Haloalkyl, C1-C8Haloalkyl, C1-C6Haloalkyl, C1-C4A haloalkyl group. Halogen and alkyl in haloalkyl are as defined herein for halogen and alkyl.
The term "C" as used herein2-CmAlkenyl "means an unsaturated open-chain hydrocarbon group having 2 to m, for example 2 to 20, 2 to 12, preferably 2 to 6, more preferably 2 to 4 carbon atoms and having one or more double bonds located anywhere, which may be branched or unbranched. Examples include ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 2-propenyl, 2-butenyl, 2-methyl-butenyl, 2-pentenyl, 2-methyl-butenyl, 2-pentenyl, 2-butenyl, 2-methyl-pentenyl, 2-methyl-pentenyl, 2-methyl-butenyl, 2-methyl-pentenyl, 2-butenyl, 2-pentenyl, 2-butenyl, 2-pentenyl, 2-methyl-butenyl, and the like, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1-dimethyl-2-propenyl, 1, 2-dimethyl-1-propenyl, 1, 2-dimethyl-2-Propenyl, 1-ethyl-1-propenyl, 1-ethyl-2-propenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl-1-pentenyl, 2-methyl-1-pentenyl, 3-methyl-1-pentenyl, 4-methyl-1-pentenyl, 1-methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-methyl-2-pentenyl, 4-methyl-2-pentenyl, 1-methyl-3-pentenyl, 2-methyl-3-pentenyl, 3-methyl-3-pentenyl, pentenyl, 4-methyl-3-pentenyl, 1-methyl-4-pentenyl, 2-methyl-4-pentenyl, 3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1-dimethyl-2-butenyl, 1-dimethyl-3-butenyl, 1, 2-dimethyl-1-butenyl, 1, 2-dimethyl-2-butenyl, 1, 2-dimethyl-3-butenyl, 1, 3-dimethyl-1-butenyl, 1, 3-dimethyl-2-butenyl, 1, 3-dimethyl-3-butenyl, 2-dimethyl-3-butenyl, 2-methyl-3-butenyl, 1, 2-dimethyl-2-butenyl, 1, 3-dimethyl-3-butenyl, 1, 2-dimethyl-3-butenyl, 1, 2-methyl-4-pentenyl, 3-pentenyl, 4-pentenyl, 3-methyl-4-pentenyl, 4-butenyl, 1, 2-dimethyl-3-butenyl, 1, 2-dimethyl-butenyl, 2-dimethyl-2-butenyl, 2-dimethyl-2-butenyl, 2-dimethyl-butenyl, 2, and the like, 2, 3-dimethyl-1-butenyl, 2, 3-dimethyl-2-butenyl, 2, 3-dimethyl-3-butenyl, 3-dimethyl-1-butenyl, 3-dimethyl-2-butenyl, 1-ethyl-1-butenyl, 1-ethyl-2-butenyl, 1-ethyl-3-butenyl, 2-ethyl-1-butenyl, 2-ethyl-2-butenyl, 2-ethyl-3-butenyl, 1, 2-trimethyl-2-propenyl, 1-ethyl-1-methyl-2-propenyl, 1-ethyl-2-methyl-1-propenyl, 2-methyl-1-butenyl, 2-methyl-2-butenyl, 2-ethyl-3-butenyl, 2-ethyl-2-butenyl, 1, 2-trimethyl-2-propenyl, 1-ethyl-1-methyl-2-propenyl, 2-methyl-1-propenyl, 2-methyl-2-propenyl, 2-methyl-2-butenyl, 2-ethyl-2-butenyl, 2-methyl-propenyl, 2-methyl-2-propenyl, 2-methyl-propenyl, 2-propenyl, 2-methyl-2-propenyl, 2-ethyl-butyl, 2-propenyl, 2, 1-ethyl-2-methyl-2-propenyl and isomers thereof. C2-C6The alkenyl group may be vinyl, propenyl, 1-butenyl, 2-butenyl, isobutenyl, 1-pentenyl, 2-pentenyl, neopentynyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, isohexenyl, neohexenyl and isomers thereof. C2-C4The alkenyl group may be vinyl, 1-propenyl, 2-propenyl, 1-methylvinyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, and isomers thereof.
The term "C" as used herein3-CmCycloalkyl "means a saturated alicyclic monocyclic group having 3 to m, such as 3 to 10, preferably 3 to 8, more preferably 5 to 6, ring carbon atoms, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl and cyclodecyl.
The term "C4-CmCycloalkylalkyl radical tableAlkyl substituted by cycloalkyl and containing a total of 4 to m carbon atoms, for example 4 to 20 carbon atoms, 4 to 12, preferably 4 to 10, 4 to 8 or 4 to 8 carbon atoms. Alkyl and cycloalkyl groups are suitably defined herein, and examples include cyclopropylmethyl, cyclopropylethyl, cyclopropylpropyl, cyclopropylbutyl, cyclobutylmethyl, cyclobutylethyl, cyclobutylpropyl, cyclobutylbutyl, cyclopentylmethyl, cyclopentylethyl, cyclopentylpropyl, cyclopentylbutyl, cyclohexylmethyl, cyclohexylethyl, cyclohexylpropyl, cyclohexylbutyl and the like.
The term "C4-CmAlkylcycloalkyl "denotes cycloalkyl substituted by alkyl and contains a total of 4 to m carbon atoms, for example 4 to 20 carbon atoms, 4 to 12, preferably 4 to 10, 4 to 8 or 4 to 8 carbon atoms. Alkyl and cycloalkyl groups are suitably defined herein, and examples include methylcyclopropyl, ethylcyclopropyl, propylcyclopropyl, butylcyclopropyl, methylcyclobutyl, ethylcyclobutyl, propylcyclobutyl, butylcyclobutyl, methylcyclopentyl, ethylcyclopentyl, propylcyclopentyl, butylcyclopentyl, methylcyclohexyl, ethylcyclohexyl, propylcyclohexyl, butylcyclohexyl, and the like.
The term "C" as used herein6-CmAryl "means a monocyclic, bicyclic or tricyclic aromatic hydrocarbon radical containing from 6 to m carbon atoms, for example from 6 to 18, preferably from 6 to 10 carbon atoms. As C6-CmAs examples of aryl groups, mention may be made of phenyl, azulenyl, cycloheptatrienyl, biphenylene, dicyclopentadiene acenyl, fluorenyl, phenanthryl, triphenylene, pyrenyl, tetracenyl, chrysenyl, biphenyl, anthracenyl, indenyl, pentalenyl and naphthyl. The aryl group may be unsubstituted or substituted. Suitable substituents include, for example, hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-8 ring members, or amino.
The term "C7-CmAralkyl "means an alkyl group substituted with an aryl group and contains 7 to m, for example, 7 to 20 carbon atoms, 7 to 12, preferably 7 to 10 carbon atoms, and more preferably 7 to 8 carbon atoms in total. Wherein alkyl and aryl are as defined herein, examples include benzyl, phenethyl, naphthylmethyl, naphthylethyl and the like.
The term "C7-CmAlkylaryl "denotes an aryl group substituted by an alkyl group and containing a total of 7 to m, such as 7 to 20, carbon atoms, for example 7 to 12, preferably 7 to 10, more preferably 7 to 8 carbon atoms. Wherein alkyl and aryl are as defined herein, examples include methylphenyl, dimethylphenyl, trimethylphenyl, ethylphenyl, diethylphenyl, triethylphenyl, methylnaphthyl, ethylnaphthyl and the like.
The term "Cn-CmAlkoxy "means at Cn-CmOpen chain C corresponding to alkyln-CmC having an oxygen atom as a linking group bonded to any carbon atom of the alkanen-CmAlkyl radicals, e.g. C1-C20Alkoxy, preferably C1-C12Alkoxy, more preferably C1-C8Alkoxy, particularly preferably C1-C6Alkoxy, particularly preferably C1-C4An alkoxy group. C1-C8The alkoxy group may be methoxy, ethoxy, propoxy, isopropoxy, n-butoxy, 2-butoxy, tert-butoxy, pentoxy, isopentoxy, hexoxy, heptoxy, octoxy, isooctoxy and isomers thereof. C1-C4The alkoxy group may be methoxy, ethoxy, propoxy, isopropoxy, n-butoxy, sec-butoxy, isobutoxy, tert-butoxy and isomers thereof.
The term "C3-CmCycloalkoxy "is defined as being in C3-CmCycloalkyl corresponds to C3-CmC having an oxygen atom as a linking group bonded to any ring carbon atom in the cycloalkane3-CmCycloalkyl radicals, examplesSuch as C3-C10Cycloalkoxy, preferably C3-C8Cycloalkoxy, more preferably C5-C6Cycloalkoxy groups, such as cyclopropyloxy, cyclobutyloxy, cyclopentyloxy, cyclohexyloxy, cycloheptyloxy, cyclooctyloxy, cyclodecyloxy and isomers thereof.
The term "C4-CmCycloalkylalkoxy "means an alkoxy group substituted with a cycloalkyl group and containing a total of 4 to m carbon atoms, for example 4 to 20, 4 to 12 carbon atoms, preferably 4 to 8 carbon atoms. Where cycloalkyl is suitably defined herein, examples include cyclopropylmethoxy, cyclopropylethoxy, cyclopropylpropoxy, cyclopropylbutoxy, cyclobutylmethoxy, cyclobutylethoxy, cyclobutylpropoxy, cyclobutylbutoxy, cyclopentylmethoxy, cyclopentylethoxy, cyclopentylpropoxy, cyclopentylbutoxy, cyclohexylmethoxy, cyclohexylethoxy, cyclohexylpropoxy, cyclohexylbutoxy and the like.
The term "C" as used herein6-CmAryloxy "means in C6-CmAryl radical corresponding to C6-CmC having an oxygen atom as a linking group bonded to any aromatic carbon atom in the aromatic hydrocarbon6-CmAryl groups such as phenoxy, tolyloxy, naphthyloxy and the like.
The term heterocycloalkyl is understood to mean a saturated radical comprising n-m ring members, such as 3-8, 3-7, 3-6 or 4-8, 4-7, 4-6, or 5, 6 or 7 ring members and one or more, such as 1-5, 1-3, 1 or 2 heteroatoms selected from N, O or S, as ring members.
Heteroaryl is understood as meaning a group having 5 to 18 ring members, for example 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 or 18, such as 5 to 16, 5 to 14, 5 to 10 or 5 to 8, or 8 to 14, 9 to 14 or 9 to 13 ring members. At least one ring atom of the heteroaryl group is a heteroatom, preferably a heteroatom selected from N, O and S, more preferably N. Heteroaryl groups preferably have 1 to 3, e.g. one or two, heteroatoms. More preferably, heteroaryl is a ring system having two or three fused rings with 8-14, 9-14 or 9-13 ring members. Examples of heteroaryl groups include carbazole, pyridinePyrrole, furan, pyrazole, imidazole and thiophene. The aryl group may be unsubstituted or substituted. Suitable substituents include, for example, hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-8 ring members, or amino.
In one embodiment of the invention, R1、R2、R3、R4And R5Independently of one another, hydrogen, halogen, nitro, cyano, amino, mono (C)1-C6Alkyl) amino, di (C)1-C6Alkyl) amino, C1-C12Alkoxy radical, C1-C12Alkyl radical, C1-C12Haloalkyl, C3-C8Cycloalkyl radical, C4-C12Cycloalkylalkyl radical, C4-C12Alkyl cycloalkyl radical, C3-C8Cycloalkoxy, C4-C12Cycloalkylalkoxy radical, C2-C6Alkenyl radical, C6-C10Aryl of (C)7-C12Aralkyl radical, C7-C12Alkylaryl and C6-C10An aryloxy group.
In a preferred embodiment of the invention, R1、R2、R3、R4And R5Independently of one another, hydrogen, halogen, amino, mono (C)1-C4Alkyl) amino, di (C)1-C4Alkyl) amino, C1-C6Alkyl radical, C1-C6Haloalkyl, C3-C8Cycloalkyl radical, C4-C8Cycloalkylalkyl radical, C4-C8Alkyl cycloalkyl radical, C2-C6Alkenyl radical, C6-C10Aryl and C7-C12An alkylaryl group.
In a preferred embodiment of the invention, R1、R2、R3、R4And R5Independently of one another, hydrogen, halogen, amino, mono (C)1-C4Alkyl) amino, di (C)1-C4Alkyl) amino, C1-C6Haloalkyl and C1-C6An alkyl group.
In a preferred embodiment of the invention, R6Is represented by C1-C12Alkyl radical, C1-C12Haloalkyl, C3-C8Cycloalkyl radical, C4-C12Cycloalkylalkyl radical, C4-C12Alkyl cycloalkyl radical, C6-C10Aryl radical, C7-C11Aralkyl and C7-C11An alkylaryl group.
In a preferred embodiment of the invention, R6Is represented by C1-C6Alkyl radical, C1-C6Haloalkyl, C3-C6Cycloalkyl radical, C4-C8Cycloalkylalkyl radical, C4-C8Alkyl cycloalkyl radical, C6-C10Aryl radical, C7-C11Aralkyl and C7-C11An alkylaryl group.
In a preferred embodiment of the invention, R6Is represented by C1-C6Alkyl radical, C5-C6Cycloalkyl radicals, quilt C5-C6Cycloalkyl-substituted C1-C6Alkyl, phenyl or C substituted by phenyl1-C6An alkyl group. Most preferred is R6Is C1-C6An alkyl group.
In one embodiment of the present invention, wherein Ar represents C6-C30Aryl or heteroaryl having 5 to 18 ring members, wherein the aryl or heteroaryl is unsubstituted or substituted with one or more (e.g., 1 to 5, 1 to 4, 1 to 3, 1 or 2) groups independently selected from the group consisting of: hydroxy, halogen, cyano, C1-C6Alkyl, aryl, heteroaryl, and heteroaryl,C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-8 ring members, or amino.
In a preferred embodiment of the invention, Ar represents C6-C20Aryl or heteroaryl having 5 to 18 ring members, wherein the aryl or heteroaryl is unsubstituted or substituted with one or more (e.g., 1 to 5, 1 to 4, 1 to 3, 1 or 2) groups independently selected from the group consisting of: hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-8 ring members, or amino.
In a preferred embodiment of the invention, Ar represents C6-C14Aryl or heteroaryl having 5 to 14 ring members, wherein the aryl or heteroaryl is unsubstituted or substituted with one or more (e.g., 1 to 5, 1 to 4, 1 to 3, 1 or 2) groups independently selected from the group consisting of: hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl, and heteroaryl,Heteroaryl or amino having 5 to 8 ring members.
Ar may be, for example, phenyl, naphthyl or carbazole, which may be selected by one or more (e.g. 1-5, 1-4, 1-3, 1 or 2) independently of one another from C1-C6Alkyl, C (O) R 'wherein R' is hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, or C6-C10And (4) an aryl group.
In a preferred embodiment of the invention, the variables in the compounds of formula (I) have the following definitions:
R1、R2、R3、R4and R5Independently of one another, hydrogen, halogen, amino, mono (C)1-C4Alkyl) amino, di (C)1-C4Alkyl) amino, C1-C6Alkyl radical, C1-C6Haloalkyl, C3-C8Cycloalkyl radical, C4-C8Cycloalkylalkyl radical, C4-C8Alkyl cycloalkyl radical, C2-C6Alkenyl radical, C6-C10Aryl and C7-C12An alkylaryl group;
R6is represented by C1-C6Alkyl radical, C1-C6Haloalkyl, C3-C6Cycloalkyl radical, C4-C8Cycloalkylalkyl radical, C4-C8Alkyl cycloalkyl radical, C6-C10Aryl radical, C7-C11Aralkyl and C7-C11An alkylaryl group; and
ar represents C6-C20Aryl or heteroaryl having 5 to 18 ring members, wherein said aryl or heteroaryl is unsubstituted or substituted with one or more groups independently selected from the group consisting of: hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ', wherein R ', R ' andr' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-8 ring members, or amino.
In a preferred embodiment of the invention, the variables in the compounds of formula (I) have the following definitions:
R1、R2、R3、R4and R5Independently of one another, hydrogen, halogen, amino, mono (C)1-C4Alkyl) amino, di (C)1-C4Alkyl) amino, C1-C6Alkyl and C1-C6A haloalkyl group;
R6is represented by C1-C6Alkyl radical, C1-C6Haloalkyl, C5-C6Cycloalkyl radicals, quilt C5-C6Cycloalkyl-substituted C1-C6Alkyl, phenyl or C substituted by phenyl1-C6An alkyl group; and
ar represents C6-C14Aryl or heteroaryl having 5 to 14 ring members, wherein said aryl or heteroaryl is unsubstituted or substituted with one or more groups independently selected from the group consisting of: hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-8 ring members, or amino.
In a preferred embodiment of the invention, the variables in the compounds of formula (I) have the following definitions:
R1、R2、R3、R4and R5Independently of each other, hydrogen, amino, mono (C)1-C4Alkyl) amino, di (C)1-C4Alkyl) amino and C1-C6An alkyl group;
R6is represented by C1-C6An alkyl group; and
ar represents C6-C14Aryl or heteroaryl having 5 to 14 ring members, wherein said aryl or heteroaryl is unsubstituted or substituted with one or more groups independently selected from the group consisting of: c1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', wherein R' is C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl or heteroaryl having 5 to 8 ring members.
Specific examples of compounds of formula (I) may be mentioned:
Figure BDA0003113238590000151
Figure BDA0003113238590000161
one aspect of the present invention relates to a γ, δ -unsaturated oxime ester compound of formula (I):
Figure BDA0003113238590000162
wherein R is1、R2、R3、R4、R5And R6Each as defined above, and
ar is a heteroaryl group having two or three fused rings and having 8 to 14, or 9 to 14 or 9 to 13 ring members, the heteroaryl group having 1 or 2N atoms as ring members, the heteroaryl group being unsubstituted or substituted with one or more (e.g. 1 to 5, 1 to 3 or 1 or 2) groups independently selected fromGroup substitution: hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-8 ring members, or amino.
In a preferred embodiment, Ar is a carbazole, which is unsubstituted or substituted by one or more (e.g. 1 to 5 or 1 to 3) substituents as defined above, preferably by one or more (e.g. 1 to 5, 1 to 4, 1 to 3, 1 or 2) substituents independently selected from C1-C6Alkyl, C (O) R 'wherein R' is hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, or C6-C10And (4) an aryl group.
In one embodiment, the compound of formula (I) is
Figure BDA0003113238590000171
A second aspect of the invention relates to a process for the preparation of a compound of formula (I) according to the invention, which comprises reacting a compound of formula (E)
Figure BDA0003113238590000172
Wherein R is1、R2、R3、R4、R5And Ar is as defined above, and (C) Ar are as defined above,
reacting with a compound of formula (F) to give a compound of formula (I)
Figure BDA0003113238590000173
Wherein X1Is halogen, hydroxy or-C (═ O) -R6And R6As defined above.
In the reaction of the compound of formula (E) with the compound of formula (F), the hydroxyl group in the oxime group is converted to an ester group, thereby obtaining the compound of formula (I). The esterification reagent is not particularly limited as long as the hydroxyl group in the oxime group of the compound of the formula (III) can be converted into an ester group. As esterification reagents, the corresponding acid halides, such as acid chlorides, the corresponding carboxylic acids and the corresponding acid anhydrides can be used.
The reaction of the compound of formula (E) with the compound of formula (F) is usually carried out in the presence of a catalyst, for example, the compound of formula (E) and the compound of formula (F) are dispersed in an organic solvent in the presence of a catalyst. As the catalyst, any one or a mixture of two or more of triethylamine, sodium carbonate, potassium carbonate, sodium bicarbonate, sodium hydroxide and sodium hydride may be mentioned. The molar ratio of the compound of formula (E) to the compound of formula (F) may be 1:2 to 1: 5; the molar ratio of compound of formula (E) to catalyst may be from 1:2 to 1: 15. Said ratio contributes to an increase in the yield of the product. In the reaction of the compound of formula (E) with the compound of formula (F), the reaction temperature may be 10 to 100 ℃ and the reaction time may be 1 to 8 hours, such as 1 to 5 hours.
According to the invention, the compounds of the formula (E) are obtainable by oximation of compounds of the formula (C) with hydroxylamine and/or hydroxylamine hydrochloride
Figure BDA0003113238590000181
Wherein R is1、R2、R3、R4、R5And Ar is as defined above.
The reaction of the compound of the formula (C) with hydroxylamine and/or hydroxylamine hydrochloride may be carried out in the presence of a catalyst. The catalyst can be any one or more of sodium bicarbonate, sodium carbonate or sodium acetate. The molar ratio of the compound of formula (C) to hydroxylamine and/or hydroxylamine hydrochloride may be 1:2 to 1: 5. The molar ratio of compound of formula (C) to catalyst may be from 1:2 to 1: 15.
According to the invention, the compounds of the formula (C) can be prepared by reacting compounds of the formula (A)
Ar-H
(A)
Wherein Ar is as defined above, and wherein,
with a compound of formula (B)
Figure BDA0003113238590000182
Wherein R is1、R2、R3、R4、R5And Ar is as defined above, and X2Is halogen.
The reaction of the compound of formula (a) with the compound of formula (B) may be carried out in the presence of a catalyst. As examples of the catalyst, there may be mentioned any one of aluminum trichloride, aluminum tribromide, ferric trichloride, boron trifluoride and zinc dichloride or a mixture of two or more thereof. The reaction is a friedel-crafts acylation reaction. The reaction temperature can be 50-150 ℃, and the reaction time can be 1-10 hours.
The reaction of the compound of the formula (A) with the compound of the formula (B), the reaction of the compound of the formula (C) with hydroxylamine and/or hydroxylamine hydrochloride, and the reaction of the compound of the formula (E) with the compound of the formula (F) may be carried out in the presence of an organic solvent. The organic solvent can be any one or the mixture of more than two of dichloromethane, chloroform, methanol, ethanol, toluene, tetrahydrofuran, N-dimethylformamide, dimethyl sulfoxide or triethylamine.
The compound of formula (I) can be used as a photoinitiator in a UV-vis photocuring system, and can effectively initiate a curing reaction. The compounds of formula (I) according to the invention can be used as photoinitiators in photocuring systems with radiation wavelengths of 300-550nm, preferably 350-525 nm. The compounds of formula (I) of the present invention may also be used as photoinitiators for 3D printing.
Another aspect of the present invention relates to photocurable compositions comprising at least one inventive gamma, delta-unsaturated oxime ester compound of formula (I).
The amount of the compounds of the formula (I) according to the invention is generally from 0.01 to 10% by weight, for example from 0.02% by weight, 0.05% by weight, 0.08% by weight, 0.1% by weight, 0.2% by weight, 0.5% by weight, 0.8% by weight, 1% by weight, 1.2% by weight, 1.5% by weight, 1.8% by weight, 2% by weight, 2.2% by weight, 2.5% by weight, 2.8% by weight, 3% by weight, 3.2% by weight, 3.5% by weight, 3.8% by weight, 4% by weight, 4.5% by weight, 5% by weight, 5.5% by weight, 6% by weight, 6.5% by weight, 7% by weight, 7.5% by weight, 8% by weight, 8.5% by weight, 9% by weight, 9.5% by weight, preferably from 0.1 to 6% by weight, such as from 0.2 to 5% by weight, based on the active ingredient amount of the photocurable composition.
In the context of the disclosure, an active ingredient refers to an ingredient of the photocurable composition excluding the solvent.
The photocurable composition contains a photocurable compound in addition to the photoinitiator of the present invention.
In the present invention, as the photocurable compound, it refers to a monomer or oligomer containing an unsaturated carbon-carbon double bond. After the monomer or the oligomer is irradiated by light, the polymerization reaction can be initiated by a photoinitiator, and then the crosslinking and curing are carried out.
According to an aspect of the present invention, there is provided a cured material obtainable from the photocurable composition of the present invention.
The cured material may be a photo-cured coating, including coatings comprising functional materials, coatings for filters of UV and/or visible light; a sealant; photoetching materials; a holographic recording material; 3D printing materials; a lithographic material; the preparation material of the optical device and the material for improving the mechanical property, such as carbon fiber composite material and/or inorganic nano particles and/or organic nano particles, etc.
The beneficial effects of the gamma, delta-unsaturated oxime ester compounds of formula (I) according to the invention as photoinitiators include:
(1) the initiation efficiency is excellent;
(2) by changing the structure and the variety of the aromatic compound, the absorption wavelength of the photoinitiator can be regulated and controlled, the photoinitiator can be used as an ultraviolet photoinitiator and a visible photoinitiator, and is matched with an energy-saving and environment-friendly LED light source for use, so that the application range is wider;
(3) the photoinitiator can be used for 3D printing to construct an exquisite three-dimensional model.
Examples
The present invention will be further described with reference to the following specific examples, which should not be construed as limiting the scope of the invention. The present invention will be further described with reference to the following specific examples, which should not be construed as limiting the scope of the invention.
Example 1: preparation of compound 1:
(1) preparation of phenyl-4-penten-1-one:
the chemical reaction formula is as follows:
Figure BDA0003113238590000201
after benzene (20mL) and aluminum trichloride (0.956g, 7.17mmol) were added in this order to a 100mL single-neck flask under ice-bath conditions, 4-pentenoyl chloride (0.728g, 6.14mmol) was slowly added dropwise thereto, and after reacting for 2 hours, the reaction mixture was poured into 20mL ice water and extracted with dichloromethane (20 mL. times.3), and the organic phases were combined and dried over anhydrous sodium sulfate. Dichloromethane was removed by rotary evaporation and separated by silica gel column chromatography to give 0.55g of a white solid, yield: 38.7 percent.
The structure of phenyl-4-penten-1-one was confirmed by nuclear magnetic resonance hydrogen spectroscopy:
1H NMR(400MHz,DMSO-d6)δ8.01–7.94(m,2H),7.67–7.60(m,1H),7.57–7.50(m,2H),5.88(ddt,J=16.8,10.2,6.4Hz,1H),5.08(dq,J=17.2,1.7Hz,1H),4.98(dq,J=10.2,1.5Hz,1H),3.13(t,J=7.3Hz,2H),2.43–2.34(m,2H)。
(2) preparation of phenyl-4-penten-1-one oxime:
the chemical reaction formula is as follows:
Figure BDA0003113238590000211
a100 mL round-bottom flask was charged with phenyl-4-penten-1-one (0.707g, 4.412mmol), hydroxylamine hydrochloride (0.613g, 8.825mmol), anhydrous sodium acetate (0.723g, 8.825mmol) and 30mL anhydrous ethanol and refluxed for 2 hours. And cooling to room temperature after the reaction is finished, filtering to remove solid impurities, collecting a liquid phase, and removing the solvent by rotary evaporation. Silica gel column chromatography (petroleum ether: ethyl acetate ═ 10:1) afforded a pale yellow solid (0.494 g). Yield: and (3.9).
The structure of phenyl-4-penten-1-one oxime was confirmed by nuclear magnetic resonance hydrogen spectroscopy:
1H NMR(400MHz,DMSO-d6)δ11.19(s,1H),7.65–7.60(m,2H),7.42–7.34(m,3H),5.84(ddt,J=16.8,10.2,6.5Hz,1H),5.04(dq,J=17.1,1.7Hz,1H),4.96(ddt,J=10.2,2.2,1.3Hz,1H),2.84–2.78(m,2H),2.21(dtt,J=9.3,6.6,1.4Hz,2H)。
(3) preparation of compound 1:
the chemical reaction formula is as follows:
Figure BDA0003113238590000212
a25 mL round bottom flask was charged with phenyl-4-penten-1-one oxime (28mg, 0.159mmol) and 5mL THF and stirred in an ice bath to add sodium hydride (7.5mg, 0.315mmol) and reacted for 30 min. Acryloyl chloride (43.4mg, 0.479mmol) was then added and the reaction continued for 30 min. After the reaction was completed, the reaction was quenched with deionized water. THF was removed by rotary evaporation and the aqueous phase was extracted three times with ethyl acetate. The organic phases were combined and dried over anhydrous sodium sulfate and ethyl acetate was removed by rotary evaporation. Column chromatography on silica gel (petroleum ether: dichloromethane ═ 1:1.5) gave 30mg of a yellow liquid. The yield was 82.3%.
The structure of compound 1 was confirmed by nuclear magnetic resonance hydrogen spectroscopy.
1H NMR(400MHz,DMSO-d6)δ7.79–7.73(m,2H),7.57–7.47(m,3H),6.48(dd,J=17.3,1.7Hz,1H),6.40(dd,J=17.3,10.1Hz,1H),6.10(dd,J=10.1,1.7Hz,1H),5.81(ddt,J=16.9,10.1,6.7Hz,1H),5.03(dq,J=17.1,1.6Hz,1H),4.98(ddt,J=10.1,2.1,1.2Hz,1H),3.00(dd,J=8.2,7.1Hz,2H),2.26(dtt,J=8.5,7.2,1.4Hz,2H).
Example 2: preparation of compound 2:
(1) preparation of N-ethylcarbazol-3- (4-butenyl) ketone:
the chemical reaction formula is as follows:
Figure BDA0003113238590000221
after methylene chloride (20mL), aluminum trichloride (0.956g, 7.17mmol) and N-ethylcarbazole (1.0g, 5.12mmol) were added in this order to a 50mL single-neck flask under ice-bath conditions, a solution of 4-pentenoyl chloride (0.728g, 6.14mmol) in methylene chloride (10mL) was slowly added dropwise, and after 4 hours of reaction, the reaction solution was poured into 20mL of ice water and extracted with methylene chloride (20 mL. times.3), and the organic phases were combined and dried over anhydrous sodium sulfate. Dichloromethane was removed by rotary evaporation and separated by silica gel column chromatography to give 0.55g of a white solid, yield: 38.7 percent.
The structure of N-ethylcarbazol-3- (4-butenyl) ketone was confirmed by nuclear magnetic resonance hydrogen spectroscopy:
1H NMR(400MHz,DMSO-d6)δ8.91(d,J=1.6Hz,1H),8.32(dt,J=7.7,1.0Hz,1H),8.10(dd,J=8.7,1.7Hz,1H),7.72–7.64(m,2H),7.52(ddd,J=8.3,7.1,1.2Hz,1H),7.29(ddd,J=7.9,7.2,0.9Hz,1H),5.94(ddt,J=16.8,10.2,6.4Hz,1H),5.17–4.96(m,2H),4.48(q,J=7.1Hz,2H),3.25(t,J=7.3Hz,2H),2.49–2.40(m,2H),1.32(t,J=7.1Hz,3H)。
(2) synthesis of N-ethyl carbazole-3- (4-butenyl) ketoxime
The chemical reaction formula is as follows:
Figure BDA0003113238590000231
n-ethylcarbazole-3- (4-N-butenyl) ketone (0.55g, 1.98mmol), hydroxylamine hydrochloride (0.412g, 5.94mmol), anhydrous sodium acetate (0.487g, 5.94mmol) and anhydrous ethanol (30mL) were added to a 100mL round-bottomed flask, and after refluxing for 2 hours, 20mL of dichloromethane was added and washed with deionized water (20mL × 3), after drying over anhydrous sodium sulfate, dichloromethane was removed by rotary evaporation, and separation by silica gel column chromatography (petroleum ether: ethyl acetate ═ 8: 1) gave 0.461g of a white solid in yield: 79.63 percent.
The structure of N-ethylcarbazole-3- (4-butenyl) ketoxime was confirmed by nuclear magnetic resonance hydrogen spectroscopy:
1H NMR(400MHz,DMSO-d6)δ10.99(s,1H),8.40(d,J=1.6Hz,1H),8.22(d,J=7.6Hz,1H),7.79(dd,J=8.6,1.7Hz,1H),7.61(dd,J=8.4,4.9Hz,2H),7.47(ddd,J=8.3,7.1,1.2Hz,1H),7.25–7.19(m,1H),5.90(ddt,J=16.8,10.2,6.5Hz,1H),5.11–4.94(m,2H),4.45(q,J=7.1Hz,2H),2.98–2.92(m,2H),2.34–2.25(m,2H),1.33(t,J=7.1Hz,3H)。
(3) synthesis of Compound 2
The chemical reaction formula is as follows:
Figure BDA0003113238590000232
n-ethylcarbazole-3- (4-butenyl) ketoxime (0.7g, 2.532mmol), sodium hydride (0.181g, 7.571mmol) and anhydrous tetrahydrofuran (20mL) were charged in a 100mL round-bottom flask under ice-bath conditions, and after 1 hour of reaction, acetyl chloride (0.685g, 7.571mmol) was added to the reaction system and the reaction was continued for 1 hour. After the reaction was completed, the reaction was quenched with saturated sodium bicarbonate solution, and the product was extracted with dichloromethane (20 mL. times.3), and the organic phases were combined and dried over anhydrous sodium sulfate. The solvent was removed by rotary evaporation and separated by silica gel column chromatography (petroleum ether: ethyl acetate 15: 1) to give 0.753g of a yellow viscous liquid, yield: 88.7 percent.
Compound 2: the structure of N-ethylcarbazole-3- (4-butenyl) ketoacetoxime ester was confirmed by nuclear magnetic resonance hydrogen spectroscopy:
1H NMR(400MHz,DMSO-d6)δ8.58(d,J=1.6Hz,1H),8.29–8.25(m,1H),7.88(dd,J=8.7,1.8Hz,1H),7.65(dd,J=14.7,8.5Hz,2H),7.50(ddd,J=8.2,7.2,1.2Hz,1H),7.28–7.23(m,1H),5.87(ddt,J=16.8,10.1,6.6Hz,1H),5.10–4.97(m,2H),4.46(q,J=7.1Hz,2H),3.09(t,J=7.7Hz,2H),2.36–2.28(m,2H),2.26(s,3H),1.32(t,J=7.1Hz,3H)。
example 3: preparation of compound 3:
(1) preparation of N-ethylcarbazole-4-butenyl-3- (2-methylphenyl) ketone:
the chemical reaction formula is as follows:
Figure BDA0003113238590000241
dichloromethane (20mL), aluminum trichloride (0.835g, 6.266mmol) and N-ethylcarbazole-3- (2-methylphenyl) ketone (0.469g, 1.566mmol) were added to a 100mL round bottom flask under ice bath conditions, and a solution of 4-pentenoyl chloride (0.247g, 1.878mmol) in dichloromethane (10mL) was slowly added dropwise to the reaction system and reacted for 4 hours. After completion of the reaction, the reaction mixture was poured into 20mL of ice water. The product was extracted with 20mL x 3 dichloromethane and the organic phases were combined and dried over anhydrous sodium sulfate. Dichloromethane was removed by rotary evaporation and separated by silica gel column chromatography (petroleum ether: ethyl acetate ═ 5: 1) to give 0.53g of a pale yellow solid in yield: 95.2 percent.
The structure of N-ethylcarbazole-4-butenyl-3- (2-methylphenyl) ketone was confirmed by nuclear magnetic resonance hydrogen spectroscopy:
1H NMR(400MHz,DMSO-d6)δ8.87(d,J=1.6Hz,1H),8.62(d,J=1.5Hz,1H),8.11(dd,J=8.6,1.7Hz,1H),7.88(dd,J=8.6,1.7Hz,1H),7.80(dd,J=8.7,6.4Hz,2H),7.59(ddd,J=8.4,5.9,2.9Hz,1H),7.43–7.35(m,3H),5.88(ddt,J=16.8,10.2,6.4Hz,1H),5.08(dq,J=17.2,1.7Hz,1H),4.88(dq,J=10.2,1.5Hz,1H),4.53(q,J=7.1Hz,2H),3.11(t,J=7.3Hz,2H),2.59(s,3H),2.43–2.34(m,2H),1.32(t,J=7.1Hz,3H)。
(2) the chemical reaction formula for synthesizing the N-ethyl carbazole-6- (2-methylbenzoyl) -4-butenyl ketoxime is as follows:
Figure BDA0003113238590000251
n-ethylcarbazole-4-butenyl-3- (2-methylphenyl) ketone (0.563g, 1.583mmol), hydroxylamine hydrochloride (0.330g, 4.751mmol), anhydrous sodium acetate (0.389g, 4.751mmol) and 25mL of anhydrous ethanol were added to a 100mL round-bottomed flask and refluxed for 3 hours. After the reaction was completed, the liquid phase was collected by filtration, the solvent was removed by rotary evaporation to obtain a crude product, which was dissolved in 20mL of dichloromethane and washed with 20 × 3mL of deionized water, and dried over anhydrous sodium sulfate, and the dichloromethane was removed by rotary evaporation, and separated by silica gel column chromatography (petroleum ether: dichloromethane ═ 1: 3) to obtain 0.594g of a pale yellow solid, yield: 96.6 percent.
The structure of N-ethylcarbazole-6- (2-methylbenzoyl) -4-butenyl ketoxime was confirmed by nuclear magnetic resonance hydrogen spectroscopy:
1H NMR(400MHz,DMSO-d6)δ11.02(s,1H),8.52(d,J=1.7Hz,1H),8.37(d,J=1.7Hz,1H),7.72(dd,J=8.7,1.7Hz,1H),7.64(dd,J=8.7,1.7Hz,1H),7.51(dd,J=18.4,8.7Hz,2H),7.49–7.45(m,1H),7.42–7.34(m,3H),5.68(ddt,J=16.8,10.2,6.4Hz,1H),5.06(dq,J=17.2,1.7Hz,1H),4.88(dq,J=10.2,1.5Hz,1H),4.45(q,J=7.1Hz,2H),3.11(t,J=7.3Hz,2H),2.69(s,3H),2.43–2.34(m,2H),1.26(t,J=7.1Hz,3H)。
(3) synthesis of Compound 3
The chemical reaction formula is as follows:
Figure BDA0003113238590000261
n-ethylcarbazole-6- (2-methylbenzoyl) -3-methylketoxime (0.594g, 1.529mmol), tetrahydrofuran (20mL) and sodium hydride (0.11g, 4.587mmol) were charged in a 100mL round-bottom flask under ice-bath conditions, and reacted for 1 hour. Then, acetyl chloride (0.415g, 4.587mmol) was added dropwise to the reaction system and the reaction was continued for 1 hour. After the reaction was completed, the reaction was quenched with saturated sodium bicarbonate, and the product was extracted with 20mL of X3 dichloromethane, and the organic phases were combined and dried over anhydrous sodium sulfate. The solvent was removed by rotary evaporation, and separation by silica gel column chromatography (petroleum ether: dichloromethane ═ 1: 3) gave 0.57g of a pale yellow liquid in yield: 90 percent.
The structure of compound 3 was confirmed by nuclear magnetic resonance hydrogen spectroscopy:
1H NMR(400MHz,DMSO-d6)8.62(d,J=1.7Hz,1H),8.47(d,J=1.7Hz,1H),7.92(dd,J=8.7,1.7Hz,1H),7.84(dd,J=8.7,1.7Hz,1H),7.71(dd,J=18.4,8.7Hz,2H),7.51–7.45(m,1H),7.42–7.34(m,3H),5.88(ddt,J=16.8,10.2,6.4Hz,1H),5.08(dq,J=17.2,1.7Hz,1H),4.98(dq,J=10.2,1.5Hz,1H),4.55(q,J=7.1Hz,2H),3.13(t,J=7.3Hz,2H),2.43–2.34(m,2H),2.69(s,3H),2.31(s,3H),1.36(t,J=7.1Hz,3H)。
example 4
The absorption performance of the gamma, delta-unsaturated oxime ester compound is measured
The performance measurements were performed on the compounds 2 and 3 prepared in examples 2 and 3, respectively, by an ultraviolet-visible spectrophotometer at 200-600 nm. The ultraviolet-visible light absorption spectra of the compounds 2 and 3 are shown in fig. 1, which illustrates that the absorption wavelength of the photoinitiator can be adjusted and controlled by changing the structure and the type of the aromatic compound (namely, Ar group), and the ultraviolet-visible light absorption spectra can be matched with a traditional high-pressure mercury lamp and an energy-saving and environment-friendly LED light source, and have a wide application range.
Example 5
Photoinitiation efficiency of gamma, delta-unsaturated oxime ester
10mg of Compound 1 of example 1 was added to 1g of trimethylolpropane triacrylate monomer under exclusion of light, and dissolved completely to give a polymer sample. A polymerized sample of the reference compound was prepared according to the same procedure, wherein the reference compound has the following structure:
Figure BDA0003113238590000271
irradiating in broad-spectrum high-pressure mercury lamp (100 mW/cm)2250-1000nm and main emission wavelength 365nm) and testing the conversion rate of the monomer by a real-time infrared spectrometer. FIG. 2 is a real-time plot of monomer conversion in a sample. The results in FIG. 2 show that the initiation efficiency of the gamma, delta-unsaturated oxime esters of the present invention is significantly higher than that of the reference compounds which do not contain a gamma, delta-unsaturated carbon-carbon double bond at the end. The polymerization rate and the conversion rate of the initiating monomer of the gamma, delta-unsaturated oxime ester are higher than those of a reference compound without gamma, delta-unsaturated carbon-carbon double bonds at the tail end.
Example 6
Application of gamma, delta-unsaturated oxime ester photoinitiator in 3D printing
Under the dark condition, adding 800mg of compound 3 and 80g of trimethylolpropane triacrylate into a glass container with a stirrer, stirring and oscillating for 24 hours to completely dissolve the compound 3 to obtain the photocuring material for 3D printing, pouring the photocuring material into a printer (mini-fab DLP) resin tank, adjusting the wavelength of a light source used by the printer to be 405nm, calling out a 3D model to be printed, and automatically printing a three-dimensional structure by the printer, wherein the three-dimensional structure is shown in figure 3.
Having described embodiments of the present invention, the foregoing description is intended to be exemplary, not exhaustive, and not limited to the embodiments disclosed. Many modifications and variations will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the described embodiments.
Example 7
10mg of Compound 1 of example 1 was added to 1g of trimethylolpropane triacrylate monomer under exclusion of light, and dissolved completely to give a polymer sample. Polymerization samples containing compound 2 and compound 3 were prepared according to the same method. Broad-spectrum high-pressure mercury lamp irradiation (100 mW/cm)2250-1000nm and main emission wavelength 365nm) and testing the conversion rate of the monomer by a real-time infrared spectrometer. FIG. 4 is a bar graph of monomer conversion after 600s of irradiation for various samples, where the monomer conversion for the system using compound 1 was about 58%, the monomer conversion for the system using compound 2 was about 69%, and the monomer conversion for the system using compound 3 was about 81%. The results in FIG. 4 show that the compounds of the present invention have good polymerization rate and conversion of monomers when used as photoinitiators, and that the initiated monomers of carbazole group-containing γ, δ -unsaturated oxime esters have higher polymerization rate and conversion than phenyl γ, δ -unsaturated oxime esters.

Claims (15)

1. Use of a gamma, delta-unsaturated oxime ester compound of formula (I) as a photoinitiator,
Figure FDA0003113238580000011
wherein R is1、R2、R3、R4And R5Independently of one another, hydrogen, halogen, nitro, cyano, amino, mono (C)1-C6Alkyl) amino, di (C)1-C6Alkyl) amino, C1-C20Alkoxy radical, C1-C20Alkyl radical, C1-C20Haloalkyl, C3-C10Cycloalkyl radical, C4-C20Cycloalkylalkyl radical, C4-C20Alkyl cycloalkyl radical, C3-C10Cycloalkoxy, C4-C20Cycloalkylalkoxy radical, C2-C20Alkenyl radical, C6-C18Aryl of (C)7-C20Aralkyl radical, C7-C20Alkylaryl and C6-C20An aryloxy group;
R6is represented by C1-C20Alkyl radical, C1-C20Haloalkyl, C3-C10Cycloalkyl radical, C4-C20Cycloalkylalkyl radical, C4-C20Alkyl cycloalkyl radical, C6-C20Aryl radical, C7-C20Aralkyl and C7-C20An alkylaryl group; and
ar represents an aryl group or a heteroaryl group.
2. Use according to claim 1, wherein R1、R2、R3、R4And R5Independently of one another, hydrogen, halogen, nitro, cyano, amino, mono (C)1-C6Alkyl) amino, di (C)1-C6Alkyl) amino, C1-C12Alkoxy radical, C1-C12Alkyl radical, C1-C12Haloalkyl, C3-C8Cycloalkyl radical, C4-C12Cycloalkylalkyl radical, C4-C12Alkyl cycloalkyl radical, C3-C8Cycloalkoxy, C4-C12Cycloalkylalkoxy radical, C2-C6Alkenyl radical, C6-C10Aryl of (C)7-C12Aralkyl radical, C7-C12Alkylaryl and C6-C10An aryloxy group;
preferably, R is1、R2、R3、R4And R5Independently of one another, hydrogen, halogen, amino, mono (C)1-C4Alkyl) amino, di (C)1-C4Alkyl) amino, C1-C6Alkyl radical, C1-C6Haloalkyl, C3-C8Cycloalkyl radical, C4-C8Cycloalkylalkyl radical, C4-C8Alkyl cycloalkyl radical, C2-C6Alkenyl radical, C6-C10Aryl and C7-C12An alkylaryl group;
more preferably R1、R2、R3、R4And R5Independently of one another, hydrogen, halogen, amino, mono (C)1-C4Alkyl) amino, di (C)1-C4Alkyl) amino, C1-C6Haloalkyl and C1-C6An alkyl group.
3. Use according to claim 1 or 2, wherein R6Is represented by C1-C12Alkyl radical, C1-C12Haloalkyl, C3-C8Cycloalkyl radical, C4-C12Cycloalkylalkyl radical, C4-C12Alkyl cycloalkyl radical, C6-C10Aryl radical, C7-C11Aralkyl and C7-C11An alkylaryl group;
preferably, R is6Is represented by C1-C6Alkyl radical, C1-C6Haloalkyl, C3-C6Cycloalkyl radical, C4-C8Cycloalkylalkyl radical, C4-C8Alkyl cycloalkyl radical, C6-C10Aryl radical, C7-C11Aralkyl and C7-C11An alkylaryl group;
more preferably, R6Is represented by C1-C6Alkyl radical, C1-C6Haloalkyl, C5-C6Cycloalkyl radicals, quilt C5-C6CycloalkanesRadical substituted C1-C6Alkyl, phenyl or C substituted by phenyl1-C6An alkyl group;
most preferred is R6Is C1-C6An alkyl group.
4. Use according to any one of claims 1 to 3, wherein Ar represents C6-C30Aryl or heteroaryl having 5 to 18 ring members, wherein said aryl or heteroaryl is unsubstituted or substituted with one or more groups independently selected from the group consisting of: hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-8 ring members, or amino;
preferably Ar represents C6-C20Aryl or heteroaryl having 5 to 18 ring members, wherein said aryl or heteroaryl is unsubstituted or substituted with one or more groups independently selected from the group consisting of: hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-8 ring members, or amino;
more preferably Ar represents C6-C14Aryl or heteroaryl having 5 to 14 ring members, wherein said aryl or heteroaryl is unsubstituted or substituted with one or more groups independently selected from the group consisting of: hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5 to 8 ring members or amino,
in particular Ar is a heteroaryl group having two or three fused rings and having 8 to 14, or 9 to 14 or 9 to 13 ring members, the heteroaryl group having 1 or 2N atoms as ring members, the heteroaryl group being unsubstituted or substituted by one or more groups independently selected from: hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-8 ring members, or amino.
5. Use according to any one of claims 1 to 4, wherein the variables in the compound of formula (I) have the following definitions:
R1、R2、R3、R4and R5Independently of one another, hydrogen, halogen, amino, mono (C)1-C4Alkyl) amino, di (C)1-C4Alkyl) amino, C1-C6Alkyl radical, C1-C6Haloalkyl, C3-C8Cycloalkyl radical, C4-C8Cycloalkylalkyl radical, C4-C8Alkyl cycloalkyl radical, C2-C6Alkenyl radical, C6-C10Aryl and C7-C12An alkylaryl group;
R6is represented by C1-C6Alkyl radical, C1-C6Haloalkyl, C3-C6Cycloalkyl radical, C4-C8Cycloalkylalkyl radical, C4-C8Alkyl cycloalkyl radical, C6-C10Aryl radical, C7-C11Aralkyl and C7-C11An alkylaryl group; and
ar represents C6-C20Aryl or heteroaryl having 5 to 18 ring members, wherein said aryl or heteroaryl is unsubstituted or substituted with one or more groups independently selected from the group consisting of: hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-8 ring members, or amino.
6. Use according to any one of claims 1 to 5, wherein the variables in the compound of formula (I) have the following definitions:
R1、R2、R3、R4and R5Independently of one another, hydrogen, halogen, amino, mono (C)1-C4Alkyl) amino, di (C)1-C4Alkyl) amino and C1-C6An alkyl group;
R6is represented by C1-C6Alkyl radical, C5-C6Cycloalkyl radicals, quilt C5-C6Cycloalkyl-substituted C1-C6Alkyl, phenyl or C substituted by phenyl1-C6An alkyl group; and
ar represents C6-C14Aryl or heteroaryl having 5 to 14 ring members, wherein said aryl or heteroaryl is unsubstituted or substituted by one or more independentlySubstituted with a group selected from: hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-8 ring members, or amino.
7. Use according to any one of claims 1 to 6, wherein the compound of formula (I) is selected from the following compounds:
Figure FDA0003113238580000041
8. use according to any one of claims 1 to 7, for the irradiation of photocuring systems with wavelengths of 300-550nm, preferably 350-525nm, in particular for 3D printing.
9. A γ, δ -unsaturated oxime ester compound of formula (I):
Figure FDA0003113238580000042
wherein R is1、R2、R3、R4、R5And R6As defined in any one of claims 1 to 7, and
ar is a heteroaryl group having two or three fused rings and having 8-14, or 9-14 or 9-13 ring members, the heteroaryl group having 1 or 2N atoms as ring members, the heteroaryl group being unsubstituted or substituted with one or more groups independently selected from: hydroxy, halogen, cyano, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-10 ring members, amino, -C (O) R ', -C (O) OR ', -OC (O) R ' ", wherein R ', R" and R ' "are each independently hydrogen, C1-C6Alkyl radical, C3-C8Cycloalkyl, heterocycloalkyl having 3 to 8 ring members, C6-C10Aryl, heteroaryl having 5-8 ring members, or amino.
10. A compound according to claim 9 which is
Figure FDA0003113238580000051
11. A process for the preparation of a compound of formula (I) as defined in any one of claims 1 to 10, which comprises reacting a compound of formula (E)
Figure FDA0003113238580000052
Wherein R is1、R2、R3、R4、R5And Ar is as defined in any one of claims 1 to 10,
reacting with a compound of formula (F) to give a compound of formula (I)
Figure FDA0003113238580000053
Wherein X1Is halogen, hydroxy or-C (═ O) -R6And R6As defined in any one of claims 1 to 10.
12. A process according to claim 11, which comprises subjecting the compound of formula (C) to an oximation reaction with hydroxylamine and/or hydroxylamine hydrochloride to give a compound of formula (E)
Figure FDA0003113238580000061
Wherein R is1、R2、R3、R4、R5And Ar is as defined in any one of claims 1 to 10.
13. A process according to claim 12, which comprises reacting a compound of formula (a)
Ar-H
(A)
Wherein Ar is as defined in any one of claims 1 to 10,
with a compound of formula (B) to prepare a compound of formula (C)
Figure FDA0003113238580000062
Wherein R is1、R2、R3、R4、R5And Ar is as defined in any one of claims 1 to 10, and X2Is halogen.
14. A photocurable composition comprising at least one γ, δ -unsaturated oxime ester compound of formula (I) according to any one of claims 1 to 10.
15. A cured material obtainable from the photocurable composition of claim 14.
CN202110659660.0A 2021-06-11 2021-06-11 Use of gamma, delta-unsaturated oxime ester compounds as photoinitiators Pending CN113336876A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202110659660.0A CN113336876A (en) 2021-06-11 2021-06-11 Use of gamma, delta-unsaturated oxime ester compounds as photoinitiators
PCT/CN2022/097591 WO2022257957A1 (en) 2021-06-11 2022-06-08 USE OF γ,δ-UNSATURATED OXIME ESTER COMPOUNDS AS PHOTOINITIATORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110659660.0A CN113336876A (en) 2021-06-11 2021-06-11 Use of gamma, delta-unsaturated oxime ester compounds as photoinitiators

Publications (1)

Publication Number Publication Date
CN113336876A true CN113336876A (en) 2021-09-03

Family

ID=77477022

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110659660.0A Pending CN113336876A (en) 2021-06-11 2021-06-11 Use of gamma, delta-unsaturated oxime ester compounds as photoinitiators

Country Status (2)

Country Link
CN (1) CN113336876A (en)
WO (1) WO2022257957A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114349622A (en) * 2022-01-24 2022-04-15 滕州市天水生物科技有限公司 Synthesis method of dimethyl cyclohexenyl pentenone
WO2022257957A1 (en) * 2021-06-11 2022-12-15 湖北固润科技股份有限公司 USE OF γ,δ-UNSATURATED OXIME ESTER COMPOUNDS AS PHOTOINITIATORS

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101410421A (en) * 2006-03-28 2009-04-15 富士胶片株式会社 Photopolymerization initiator, photosensitive composition, photosensitive film, photosensitive laminate, method of forming permanent pattern and printed board
CN101981063A (en) * 2008-03-28 2011-02-23 富士胶片株式会社 Polymerizable composition, color filter, method for producing color filter, and solid-state imaging device
TW201629626A (en) * 2015-02-06 2016-08-16 奇美實業股份有限公司 Blue photosensitive resin composition for color filters and uses thereof
CN105867068A (en) * 2015-02-06 2016-08-17 奇美实业股份有限公司 Blue photosensitive resin composition for color filter and application thereof
CN106569388A (en) * 2015-09-30 2017-04-19 奇美实业股份有限公司 Photosensitive resin composition for black matrix and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113336876A (en) * 2021-06-11 2021-09-03 湖北固润科技股份有限公司 Use of gamma, delta-unsaturated oxime ester compounds as photoinitiators

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101410421A (en) * 2006-03-28 2009-04-15 富士胶片株式会社 Photopolymerization initiator, photosensitive composition, photosensitive film, photosensitive laminate, method of forming permanent pattern and printed board
CN101981063A (en) * 2008-03-28 2011-02-23 富士胶片株式会社 Polymerizable composition, color filter, method for producing color filter, and solid-state imaging device
TW201629626A (en) * 2015-02-06 2016-08-16 奇美實業股份有限公司 Blue photosensitive resin composition for color filters and uses thereof
CN105867068A (en) * 2015-02-06 2016-08-17 奇美实业股份有限公司 Blue photosensitive resin composition for color filter and application thereof
CN106569388A (en) * 2015-09-30 2017-04-19 奇美实业股份有限公司 Photosensitive resin composition for black matrix and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
王永信: "《光固化3D打印技术》", 30 November 2018, 华中科技大学出版社 *
谷珉珉, 复旦大学出版社 *
谷珉珉: "《有机化学实验》", 30 November 1991, 复旦大学出版社 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022257957A1 (en) * 2021-06-11 2022-12-15 湖北固润科技股份有限公司 USE OF γ,δ-UNSATURATED OXIME ESTER COMPOUNDS AS PHOTOINITIATORS
CN114349622A (en) * 2022-01-24 2022-04-15 滕州市天水生物科技有限公司 Synthesis method of dimethyl cyclohexenyl pentenone
CN114349622B (en) * 2022-01-24 2024-01-26 滕州市天水生物科技有限公司 Synthesis method of dimethyl cyclohexenyl pentenone

Also Published As

Publication number Publication date
WO2022257957A1 (en) 2022-12-15

Similar Documents

Publication Publication Date Title
WO2022257957A1 (en) USE OF γ,δ-UNSATURATED OXIME ESTER COMPOUNDS AS PHOTOINITIATORS
JP6910533B2 (en) Coumarin oxime ester compounds and their preparation and use
CN112279864B (en) Difunctional coumarin oxime ester compound and preparation and application thereof
EP2407456B1 (en) Carbazole oxime ester photoinitiator
KR102047043B1 (en) UV-LED photocuring sensitizer, manufacturing method thereof and use thereof
CN108117488B (en) Benzoyl methyl cinnamate compound and preparation method and application thereof
CN113816844A (en) Bio-based epoxy resin monomer and preparation method and application thereof
CN107793502B (en) Oxime ester photoinitiator, preparation method thereof, photocuring composition and application thereof
CN109651116A (en) Solvent-free microwave method synthesizes 4- phenylmethylene -2,6- di-t-butyl -2,5- cyclohexadiene -1- ketone
WO2024041569A1 (en) Acyloxyphosphine oxime ester compound suitable for deep curing of uv-vis led light sources, method for preparing same, and use thereof
JPH01139546A (en) 3,5-disubstituted-4-acetoxystyrene and its production
CN110563589B (en) Mono-or di-methyl cinnamate photoinitiator, and preparation method and application thereof
Watkins et al. Synthesis and photophysical characterization of aryl-substituted polynorbornenediol acetal and ketal multiblock copolymers
CN113527138B (en) Para-fluorobenzoyl oxime ester photoinitiator for preparing photochromic material as well as preparation method and application thereof
CN114181110A (en) Bisphenol fluorene oxime ester photoinitiator and preparation method and application thereof
Myers et al. Synthesis of the naphthoic acid component of kedarcidin chromophore by routes employing photochemical and thermal electrocyclic ring closure reactions
WO2024067718A1 (en) Ether-functionalized coumarin oxime ester compound, and preparation and use thereof
CN110551098A (en) oxime ester photoinitiator containing five-membered aromatic heterocyclic structure and preparation and application thereof
CN115707681B (en) Naphthalene sensitizer, process for producing the same, photocurable composition and photocurable product
CN118184557B (en) Oxime ester photoinitiator based on chalcone and preparation method and application thereof
CN115286641B (en) Thioxanthone single-component visible light initiator and preparation method and application thereof
CN109503477A (en) A kind of triarylmethane class compound and its efficient catalytic synthetic method
CN110563588B (en) Mono-or di-cinnamate photoinitiator, and preparation method and application thereof
CN113717207B (en) Method for synthesizing indene compounds
CN112142955B (en) Adamantane-polyphenol oligomer, photoresist composition and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination